Portfolio Management - Our partners

Midwinter are contracted exclusively to distribute drugs for use in clinical trials with the following partners; 

Sun Pharmaceutical Industries  – Exclusive agreement with one of the largest generic manufacturers in the world, with an expansive and diverse portfolio.

Accord Pharmaceuticals – Exclusive access to the full solid dose portfolio of Europe’s largest generic manufacturer.

SeaCross Pharmaceuticals – Exclusive European wide access to Seacross’s rapidly growing injectable oncology portfolio.


Midwinter provides unique distribution services on behalf of some of the worlds leading pharmaceutical manufacturers.

By working hand in hand with these manufacturers, Midwinter can exclusively access generic drugs enabling us to provide simple and seamless supply of supporting medications to clinical trials. 

Read more


Midwinter offers unrivalled experience in every aspect of clinical trials.

Recognising the opportunity to provide a scalable service, one that treats a single syringe the same way that it treats the supply of ten thousand vials of drug. We serve a broad spectrum of global partners...

Read more